Archives

A Case-Based Overview of Autosomal Dominant Polycystic Kidney Disease
Join autosomal dominant polycystic kidney disease (ADPKD) experts, where you can hear the most current information on ADPKD pathophysiology, disease progression, and the physical and emotional burden of ADPKD.
Objectives
- Review of the recent advancements made in the ADPKD field
- Address key factors that play into ADPKD
- Highlight and evaluate prognostic indicators of advanced ADPKD outcomes
*Drs Aaron Emmel and Tazin Aijaz are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).
Featured Speakers

Aaron Emmel, PharmD, MHA, BCPS

Tazin Aijaz, PharmD, BCPS
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Tazin Aijaz, PharmD, BCPS, is a Nephrology Medical Science Director at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy from the University of Cincinnati in Cincinnati, Ohio and then completed her clinical residency training at the Atlanta VA Medical Center with a focus in internal medicine and psychiatry. Prior to joining Otsuka, Dr Aijaz held various positions within the pharmaceutical industry in several therapeutic areas including immunology, movement disorders, and epilepsy.